Framework for continuous palliative sedation therapy in Canada

Journal of Palliative Medicine

Volumn 15, Issue 8, 2012, Pages 870-879

  Dean, Mervyn M ^a   Cellarius, Victor ^b   Henry, Blair ^c,d   Oneschuk, Doreen ^e   Librach, S Lawrence ^d  

^a Western Memorial Regional Hospital   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

^c SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e GREY NUNS COMMUNITY HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE; HALOPERIDOL; OPIATE;

ARTICLE; CANADA; CONSULTATION; CONTINUOUS PALLIATIVE SEDATION THERAPY; CULTURAL FACTOR; EUTHANASIA; HUMAN; MEDICAL DECISION MAKING; PALLIATIVE THERAPY; PATIENT MONITORING; PRACTICE GUIDELINE; SEDATION; TERMINAL CARE;

CANADA; CONSENSUS; DEEP SEDATION; HEALTH POLICY; HUMANS; HYPNOTICS AND SEDATIVES; PAIN, INTRACTABLE; PALLIATIVE CARE; PRACTICE GUIDELINES AS TOPIC;

EID: 84864577711     PISSN: 10966218     EISSN: 15577740     Source Type: Journal    
DOI: 10.1089/jpm.2011.0498     Document Type: Article

References (62)

1. Schüklenk U, van Deiden JJ, Downie J, Mclean SA, Upshir R, Weinstock D: End-of-life decision making in Canada: The report by The Royal Society of Canada, Expert Panel Report on: End-of-life Decision Making. Bioethics 011;25Suppl1:1-73.
2. Ventafridda V, Ripamonti C, de Conno F, Tamburini M: Symptom prevalence and control during cancer patients' last days of life. J Palliat Care 1990;6:7-11.
3. Enck RE: Drug-induced terminal sedation for symptom control. Am J Hosp Palliat Care 1991;8:3-5.
4. Billings JA, Block SD: Slow euthanasia. J Palliat Care 1996;12:21-30
5. Mount BM: Morphine drips, terminal sedation, and slow euthanasia: Definitions and facts, not anecdotes. J Palliat Care 1996;12:31-37.
6. Rietjens JA, van der Heide A, Vrakking AM, Onwuteaka- Philipsen BD, van der Maas PJ, van der Wal G: Physician reports of terminal sedation without hydration or nutrition for patients nearing death in the Netherlands. Ann Intern Med 2004;141:178-185.
7. Chambaere K, Bilsen J, Cohen J, Rietjens JA, Onwuteaka- Philipsen BD, Mortier F, Deliens L: Continuous deep sedation until death in Belgium: A nationwide survey. Arch Intern Med 2010;170:490-493.
8. Lewis C.:Euthanasia ''favorable'' to Quebec MDs: Survey. National Post, October 13, 2009.
9. Berger JT: Rethinking guidelines for the use of palliative sedation. Hastings Centre Report 2010;40:32-38.
10. Royal Dutch Medical Association: National guideline for palliative sedation. Utrecht, The Netherlands: Royal Dutch Medical Association, 2005. Table 3. Aspects of CPST Requiring Monitoring Relief of suffering as assessed by verbal comments of the patient or the caregiver(s), facial expressions, and/or body movements or posture. Level of consciousness (depth of sedation) as assessed by responses to verbal or nonpainful physical (mechanical) stimuli. Adverse effects related to sedation. Depending on the depth of sedation, this might include susceptibility to limb/joint injury, skin breakdown, respiratory depression, etc
11. Morita T, Bito S, Kurihara Y, Uchitomi Y: Development of a clinical guideline for palliative sedation therapy using the Delphi method. J Palliat Med 2005;8:716-729.
12. Kirk TW, Mahon MM for the Palliative Sedation Task Force of the National Hospice and Palliative Care Organization Ethics Committee: National Hospice and Palliative Care Organization (NHPCO) position statement and commentary on the use of palliative sedation in imminently dying terminally ill patients. J Pain Symptom Manage 2010;39:914-923.
13. Cherny NI, Radbruch L: European Association for Palliative Care (EAPC) recommended framework for the use of sedation in palliative care. Palliat Med 2009;23:581-593.
14. Braun TC, Hagen NA, Clark T: Development of a clinical practice guideline for palliative sedation. J Palliat Med 2003;6:345-350.
15. Downing GM, Black F: Palliative sedation framework and guideline. In: Downing GM, Wainwright W, (eds): Medical Care of the Dying, 4th ed. Victoria: Victoria Hospice Society, 2006, pp. 605-615.
16. Fainsinger RL, Waller A, Bercovici M, et al.: A multicenter international study for uncontrolled symptoms in terminally ill patients. Palliat Med 2000;14:257-265.
17. Krakauer EL, Penson RT, Truog RD, King LA, Chabner BA, Lynch TJ Jr: Sedation for intractable distress of a dying patient: Acute palliative care and the principle of double effect. Oncologist 2000;5:53-62.
18. Levy MH, Cohen SD: Sedation for the relief of refractory symptoms in the imminently dying: A fine international line. Semin Oncol 2005;32:237-246.
19. Cherny NI: Sedation in response to refractory existential distress: Walking the fine line. J Pain Symptom Manage. 1998;16:404-406.
20. Taylor BR, McCann RM: Controlled sedation for physical and existential suffering? J Palliat Med 2005;8:144-147.
21. Morita T, Tsunoda J, Inoue S, Chihara S: Terminal sedation for existential distress. Am J Hosp Palliat Care 2000;17:189-195.
22. Morita T: Palliative sedation to relieve psycho-existential suffering of terminally ill cancer patients. J Pain Symptom Manage 2004;28:445-450
23. Rousseau P: Existential suffering and palliative sedation in terminal illness Prog Palliat Care 2002;10:222-224.
24. Roussean P: Existential suffering and palliative sedation in terminal illness. Prog Palliat Care 2002;10:222-224.
25. Shaiova L: Case presentation: Terminal sedation and existential distress. J Pain Symptom Manage 1998;16:403-404.
26. Blondeau D, Roy L, Dumont S, Godin G, Martineau I: Physicians' and pharmacists' attitudes toward the use of sedation at the end of life: Influence of prognosis and type of suffering. J Palliat Care 2005;21:238-245.
27. Schuman-Oliver Z, Brendel DH, Ferstein M, Price BH: The use of palliative sedation for existential distress: A psychiatric perspective. Harvard Rev Psychiatry 2008;: 339-351.
28. Rousseau P: Palliative sedation in terminally ill patients. In: C. Machada, Shewman DD (eds): Brain Death and Disorders of Consciousness. New York: Kluwer Academic/Plenum, 2004, pp. 263-267.
29. Cherny NI, Portenoy RK: Sedation in the management of refractory symptoms: Guidelines for evaluation and treatment. J Palliat Med 1994;10:31-38.
30. De Graeff A, Dean M: Palliative sedation therapy in the last weeks of life: A literature review and recommendations for standards. J Palliat Med 2007;10:67-85.
31. Rousseau P: The ethical validity and clinical experience of palliative sedation. Mayo Clin Proc 2000;75:1064-1069.
32. Chater S, Viola R, Paterson J, Jarvis V: Sedation for intractable distress in the dying: A survey of experts. Palliat Med 1998;12:255-269.
33. Beel A, McClement SE, Harlos M: Palliative sedation therapy: A review of definitions and usage. Int J Palliat Nurs 2002;8:190-199.
34. Boyle J: Medical ethics and double effect: The case of terminal sedation. Theor Med Bioeth 2004;25:51-60.
35. McIntyre A: The double life of double effect. Theor Med Bioeth 2004;25:61-74.
36. Quill TE, Dresser R, Brock DW: The rule of double effect-a critique of its role in end-of-life decision making. N Engl J Med 1997;337:1768-1771.
37. Quill TE, Lo B, Brock DW: Palliative options of last resort: A comparison of voluntarily stopping eating and drinking, terminal sedation, physician-assisted suicide, and voluntary active euthanasia. JAMA 1997;278:2099-2104.
38. Gillon R: Foreseeing is not necessarily the same thing as intending. BMJ 1999;318:1431-1432.
39. Sulmasy DP, Pellegrino ED: The rule of double effect: Clearing up the double talk. Arch Intern Med 1999;159:545-550.
40. Maltoni M, Pittureri C, Scarpi E, Piccinini L, Martini F, Turci P, Montanari L, Nanni O, Amadori D: Palliative sedation therapy does not hasten death: Results from a prospective multicenter study. Ann Oncol 2009; 20:1163-1169.
41. Sykes N, Thorns A: The use of opiods and sedatives at the end of life. Lancet Oncol 2003;4:312-318.
42. Muller-Busch HC, Andres I, Jehser T: Sedation in palliative care: A critical analysis of 7 years experience. BMC Palliat Care 2003;2: 1-9.
43. Sneiderman B: Decision-making at the end of life. In: Downie J, Caulfield T, Flood C (eds): Canadian Health Law and Policy. Markham and Vancouver, Canada: Butterworths, 2002, pp. 501-531.
44. Joint Centre for Bioethics: Aid To Capacity Evaluation (ACE). www.utoronto.ca/jcb/disclaimers/ace.htm (Last accessed
45. Jansen LA, Sulmasy DP: Sedation, alimentation, hydration and equivocation: Careful conversation about care at the end of life. Ann Intern Med 2002;136: 845-849.
46. Viola RA, Wells GA, Petersen J: The effects of fluid status and fluid therapy on the dying: A systematic review. J Palliat Care 1997;13:41-52.
47. Broeckaert B, Nunez Olarte JM: Sedation in palliative care: Facts and concepts. In: Ten Have H, Clark D (eds.): The Ethics of Palliative Care: European Perspectives. Buckingham: Open University Press, 2002, pp. 166-180.
48. Rietjens JA, van Delden JJ, van der Heide A, Vrakking AM, Onwuteaka-Philipsen BD, van der Maas PJ, van der Wal G: Terminal sedation and euthanasia: A comparison of clinical practices. Arch Intern Med 2006; 166:749-753.
49. Gillon R: Palliative care ethics: Non-provision of artificial nutrition and hydration to terminally ill sedated patients J Med Ethics 1994;20:131-132.
50. Purnell L: The Purnell Model for Cultural Competence. J Multicult Nursi Health (Summer 2005). http://findarticles. com/p/articles/mi-qa3919/is-200507/ ai-n14825638/ (Last accessed)
51. Polacek GNLJ, Martinez R: Assessing cultural competence at a local hospital system in the nited States. Health Care Manager 2009;28:98-110.
52. McWilliams K, Keeley PW, Waterhouse ET: Propofol for terminal sedation in palliative care: A systematic review. J Palliat Med 2010;13:73-76.
53. Twycross R, Wilcock A, Dean M, Kennedy B: Palliative Care Formulary [Canadian edition]. Nottingham,UK: Palliativedrugs. com, 2010, pp. 226-230.
54. Morita T, Tsunoda J, Inoue S, Chihara S, Oka K: Communication Capacity Scale and the Agitation Distress Scale to measure the severity of delirium in terminally ill cancer patients: A validation study. J Pain Symptom Manage 2001;15;197-206.
55. Ramsay MAE, Savage TM, Simpson BRJ, Goodwin R: Controlled sedation with alpaxalone-alphadolone.Br Med J 1974; 2:656-659.
56. Ely EW, Truman B, Shintani A, Thomason JW, Wheeler AP, Gordon S, et al.: Monitoring sedation status over time in ICU patients: Reliability and validity of the Richmond Agitation- Sedation Scale (RASS). JAMA 2003;289: 2983-2991.
57. Devlin JW, Boleski G, Mlynarek M, Nerenz DR, Peterson E, Jankowski M, Horst HM, Zarowitz BJ: Motor Activity Assessment Scale: A valid and reliable sedation scale for use with mechanically ventilated patients in an adult surgical intensive care unit. Crit Care Med 1999;27:1271-1275.
58. Teasdale G, Jennett B: Assessment of coma and impaired consciousness. Lancet 1974;2:81-84.
59. Gonçalves F, Bento MJ, Alvarenga M, Costa I, Costa L: Validation of a Consciousness Level Scale for palliative care. Palliat Med 2008;22:724-729.
60. Rousseau P: Existential suffering and palliative sedation: A brief commentary with a proposal for clinical guidelines. Am J Hospice Palliat Care 2001;18:151-153.
61. Morita T, Inoue S, Chihara S Sedation for symptom control in Japan: The importance of intermittent use and communication with family members. J Pain Symptom Manage 1996; 12:32-38.
62. Chiu T-Y, Hu W-Y, Lue B-H, Cheng S-Y, Chen C-Y: Sedation for refractory symptoms of terminal cancer patients in Taiwan. J Pain Symptom Manage 2001;21:467-472.